Tuberculosis in renal transplant recipients: The evidence for prophylaxis

Transplantation

Volumn 90, Issue 7, 2010, Pages 695-704

  Currie, Andrew C ^a   Knight, Simon R ^a   Morris, Peter J ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Prophylaxis; Renal transplant; Systematic review; Tuberculosis

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; INTERLEUKIN 2 RECEPTOR; ISONIAZID; MYCOPHENOLIC ACID; PLACEBO; PREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG WITHDRAWAL; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; GRAFT RECIPIENT; HEPATITIS; HUMAN; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK BENEFIT ANALYSIS; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DEMOGRAPHY; HUMANS; ISONIAZID; KIDNEY TRANSPLANTATION; MYCOBACTERIUM TUBERCULOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; TUBERCULOSIS;

EID: 77958003198     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181ecea8d     Document Type: Review

References (75)

1. API Consensus Expert Committee. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations. J Assoc Physicians India 2006; 54: 219.
2. Munoz P, Rodriguez C, Bouza E, et al. Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis 2005; 40: 581.
3. Moosa MR. Renal transplantation in developing countries. In: Morris PJ, ed. Kidney Transplantation: Principles and Practice [ed. 6]. Philadelphia, Elsevier 2008.
4. Cavusoglu C, Cicek-Saydam C, Karasu Z, et al. Mycobacterium tuberculosis infection and laboratory diagnosis in solid-organ transplant recipients. Clin Transplant 2002; 16: 257.
5. Ram R, Swarnalatha G, Prasad N, et al. Tuberculosis in renal transplant recipients. Transpl Infect Dis 2007; 9: 97.
6. Krance MB, Fisher MA. Prophylaxis of mycobacterial infections in immunocompromised patients. Am Fam Physician 1996; 54: 1981.
7. Dridi A, Kaaroud H, Boubaker K, et al. Tuberculosisin renal transplant recipients. Transplant Proc 2003; 35: 2682.
8. Sepulveda RL, Ferrer X, Latrach C, et al. The influence of Calmette-Guerin bacillus immunization on the booster effect of tuberculin testing in healthy young adults. Am Rev Respir Dis 1990; 142: 24.
9. Huebner RE, Schein MF, Bass JBJr. The tuberculin skin test. Clin Infect Dis 1993; 17: 968.
10. Wang L, Turner MO, Elwood RK, et al. A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax 2002; 57: 804.
11. Lalvani A. Diagnosing tuberculosis infection in the 21st century: New tools to tackle an old enemy. Chest 2007; 131: 1898.
12. Menzies D, Pai M, Comstock G. Meta-analysis: New tests for the diagnosis of latent tuberculosis infection: Areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146: 340.
13. Pai M, Riley LW, Colford JM Jr. Interferon-gamma assays in the im-munodiagnosis of tuberculosis: A systematic review. Lancet Infect Dis 2004; 4: 761.
14. Centers for Disease Control and Prevention. The use of preventive therapy for tuberculosis infection in the United States. Recommendations of the Advisory Committee for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep 1990; 39: 9.
15. International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull World Health Organ 1982; 60: 555.
16. Pape JW, Jean SS, Ho JL, et al. Effect if isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 1993; 342: 268.
17. Whalen CC, Johnson JL, Okwera A, et al. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. N Engl J Med 1997; 337: 801.
18. Jadad AR, Moore RA, Carroll D, et al. Assessing the qualityof reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996; 17: 1.
19. Pengel L, Barcena L, Morris PJ, et al. Registry of randomized controlled trials in transplantation. Transplantation 2005; 80: 432.
20. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539.
21. Naqvi R, Akhtar S, Noor H, et al. Efficacy of isoniazid prophylaxis in renal allograft recipients. Transplant Proc 2006; 38: 2057.
22. NaqviR, Naqvi A, AkhtarS, et al. Useof isoniazid chemoprophylaxis in renal transplant recipients. Nephrol Dial Transplant 2010; 25: 634.
23. Yildiz A, Sever MS, Turkmen A, et al. Tuberculosis after renal transplantation: Experience of one Turkish centre. Nephrol Dial Transplant 1998; 13: 1872.
24. Spence RK, Dafoe DC, Rabin G, et al. Mycobacterial infections in renal allograft recipients. Arch Surg 1983; 118: 356.
25. Higgins RM, Cahn AP, Porter D, et al. Mycobacterial infections after renal transplantation. Quart J Med 1991; 78: 145.
26. Matuck TA, Brasil P, Alvarenga Mde F, et al. Tuberculosis in renal transplants in Rio de Janeiro. Transplant Proc 2004; 36: 905.
27. Apaydin S, Altiparmak MR, Serdengecti K, et al. Mycobacterium tuberculosis infections after renal transplantation. Scand J Infect Dis 2000; 32: 501.
28. Sayiner A, Ece T, Duman S, et al. Tuberculosis in renal transplant recipients. Transplantation 1999; 68: 1268.
29. John GT, Thomas PP, Thomas M, et al. A double-blind randomized controlled trial of primary isoniazid prophylaxis in dialysis and transplant patients. Transplantation 1994; 57: 1683.
30. Agarwal SK, Gupta S, Dash SC, et al. Prospective randomised trial of isoniazid prophylaxis in renal transplant recipient. Int Urol Nephrol 2004; 36: 425.
31. Vikrant S, Agarwal SK, Gupta S, et al. Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy. Transplant Infect Dis 2005; 7: 99.
32. John GT, Shankar V, Abraham AM, et al. Risk factors for post-transplant tuberculosis. Kidney Int 2001; 60: 1148.
33. Basiri A, Hosseini-Moghaddam SM, Simforoosh N, et al. The risk factors and laboratory diagnostics for post renal transplant tuberculosis: A case-control, country-wide study on definitive cases. Transplant Infect Dis 2008; 10: 231.
34. Klote MM, Agodoa LY, Abbott KC. Risk factors for Mycobacterium tuberculosis in US chronic dialysis patients. Nephrol Dial Transplant 2006; 21: 3287.
35. Shankar MS, Aravindan AN, Sohal PM, et al. The prevalence of tuberculin sensitivity and anergy in chronic renal failure in an endemic area: Tuberculin test and the risk of post-transplant tuberculosis. Nephrol Dial Transplant 2005; 20: 2720.
36. Passalent L, Khan K, Richardson R, et al. Detecting latent tuberculosis infection in hemodialysis patients: A head-to-head comparison of the T-SPOT.TB test, tuberculin skin test, and an expert physician panel. Clin J Am Soc Nephrol 2007; 2: 68.
37. Hursitoglu M,Cikrikcioglu MA, Tukek T, et al. Acute effect of low-flux hemodialysis process on the results of the interferon-gamma-based QuantiFERON-TB Gold In-Tube test in end-stage renal disease patients. Transpl Infect Dis 2009; 11: 28.
38. Triverio PA, Bridevaux PO, Roux-Lombard P, et al. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients. Nephrol Dial Transplant 2009; 24: 1952.
39. Manuel O, Humar A, Preiksaitis J, et al. Comparison of Quantiferon-TB gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation. Am J Transplant 2007; 7: 2797.
40. Lindemann M, Dioury Y, Beckebaum S, et al. Diagnosis of tuberculosis infection in patients awaiting liver transplantation. Hum Immunol 2009; 70: 24.
41. Berthoux F, Abramowicz D, Bradley B, et al. Section IV: Long-term management of the transplant recipient. Nephrol Dial Transplant 2002; 17: 3.
42. Subramanian A, Dorman S. Mycobacterium tuberculosis in solid organ transplant recipients. Am J Transplant 2009; 9(suppl 4): S57.
43. Antony SJ, Ynares C, Dummer JS. Isoniazid hepatotoxicity in renal transplant recipients. Clin Transplant 1997; 11: 34.
44. Agarwal SK, Srivastava RK. Chronic kidney disease inIndia: Challenges and solutions. Nephron Clin Pract 2009; 111: c197.
45. Langhoff E, Madsen S. Rapid metabolism of cyclosporin and pred-nisolone in kidney-transplant patient receiving tuberculostatic treatment. Lancet 1983; 2: 1031. (Pubitemid 14225080)
46. Mibu H, Yoshida K, Kagebayashi Y, et al. Low ciclosporin blood levels induced by antituberculous drugs in a renal transplant patient. Jpn J Transplant 1999; 34: 46.
47. Peschke B, Ernst W, Gossmann J, et al. Antituberculous drugsinkidney transplant recipients treated with cyclosporine. Transplantation 1993; 56: 236.
48. Sud K, Muthukumar T, Singh B, et al. Isoniazid does not affect bio-availability of cyclosporine in renal transplant recipients. Methods Find Exp Clin Pharmacol 2000; 22: 647.
49. Holty JE, Gould MK, Meinke L, et al. Tuberculosis in liver transplant recipients: A systematic review and meta-analysis of individual patient data. Liver Transpl 2009; 15: 894.
50. Naqvi A, Rizvi A, Hussain Z, et al. Developing world perspective of posttransplant tuberculosis: Morbidity, mortality, and cost implications. Transplant Proc 2001; 33: 1787
51. WHO. World Health Organisation Report 2008: Global tuberculosis control. Surveillance, Planning, Financing. Geneva, WHO 2008.
52. Lattes R, Radisic M, Rial M, et al. Tuberculosis in renal transplant recipients. Transplant Infect Dis 1999; 1: 98.
53. Vandermarliere A, Van Audenhove A, Peetermans WE, et al. Mycobac-terial infection after renal transplantation in a Western population. Transplant Infect Dis 2003; 5: 9.
54. Zhang XF, Lv Y, Xue WJ, et al. Mycobacterium tuberculosis infection in solid organ transplant recipients: Experience from a single center in China. Transplant Proc 2008; 40: 1382.
55. Lui SL, Tang S, Li FK, et al. Tuberculous infection in southern Chinese renal transplant recipients. Clin Transplant 2004; 18: 666.
56. Sakhuja V, Jha V, Varma PP, et al. The high incidence of tuberculosis among renal transplant recipients in India. Transplantation 1996; 61: 211.
57. Jha R, Narayan G, Jaleel MA, et al. Pulmonary infections after kidney transplantation. J Assoc Physicians India 1999; 47: 779.
58. Sharma AK, Tolani SL, Rathi GL, et al. Tuberculosis after renal transplantation. Transplant Proc 2000; 32: 1959.
59. Aslani J, Einollahi B. Prevalence of tuberculosis after renal transplantation in Iran. Transplant Proc 2001; 33: 2804.
60. Basiri A, Moghaddam SM, Simforoosh N, et al. Preliminary report of a nationwide case-control study for identifying risk factors of tuberculosis following renal transplantation. Transplant Proc 2005; 37: 3041.
61. Ghafari A, Makhdoomi K, Ahmadpoor P, et al. Tuberculosis in Iranian kidney transplant recipients: A single-center experience. Transplant Proc 2007; 39: 1008.
62. Melchor JL, Gracida C, IbarraA. Increased frequency of tuberculosis in Mexican renal transplant recipients: A single-center experience. Transplant Proc 2002; 34: 78.
63. Koselj M, Kandus A, Ales A, Bren AF et al. Mycobacterial infection in renal transplant recipients. Transplant Proc 2000; 32: 152.
64. Hall CM, Willcox PA, Swanepoel CR, et al. Mycobacterial infection in renal transplant recipients. Chest 1994; 106: 435.
65. Queipo JA, Broseta E, Santos M, et al. Mycobacterial infection in a series of 1261 renal transplant recipients. Clin Microbiol Infect 2003; 9: 518.
66. Chen CH, Lian JD, Cheng CH, et al. Mycobacterium tuberculosis infection following renal transplantation in Taiwan. Transplant Infect Dis 2006; 8: 148.
67. Hsu MS, Wang JL, Ko WJ, et al. Clinical features and outcome of tuberculosis in solid organ transplant recipients. Am J Med Sci 2007; 334: 106.
68. Ruangkanchanasetr P, Natejumnong C, Kitpanich S, et al. Prevalence and manifestations of tuberculosis in renal transplant recipients: A single-center experience in Thailand. Transplant Proc 2008; 40: 2380.
69. Kaaroud H, Beji S, Boubaker K, et al. Tuberculosis after renal transplantation. Transplant Proc 2007; 39: 1012.
70. Atasever A, Bacakoglu F, Toz H, et al. Tuberculosis in renal transplant recipients on various immunosuppressive regimens. Nephrol Dial Transplant 2005; 20: 797.
71. Ergun I, Ekmekci Y, Sengul S, et al. Mycobacterium tuberculosis infection in renal transplant recipients. Transplant Proc 2006; 38: 1344.
72. Koseoglu F, Emiroglu R, Karakayali H, et al. Prevalence of mycobacterial infection in solid organ transplant recipients. Transplant Proc 2001; 33: 1782.
73. Klote MM, Agodoa LY, Abbott K, et al. Mycobacterium tuberculosis infection incidence in hospitalized renal transplant patients in the United States, 1998-2000. Am J Transplant 2004; 4: 1523.
74. Jie T, Matas AJ, Gillingham KJ, et al. Mycobacterial infections after kidney transplant. Transplant Proc 2005; 37: 937.
75. Lezaic V, Radivojevic R, Radosavljevic G, et al. Does tuberculosis after kidney transplantation follow the trend of tuberculosis in general population? Ren Fail 2001; 23: 97.